Elizabeth Debra Cedars, MD
Otolaryngology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 13 years
- University of California, San Francisco School of Medicine, 2013
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Hospitals listed: Adventist Health Ukiah Valley · Marinhealth Medical Center · Petaluma Valley Hospital · Providence Santa Rosa Memorial Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cedars’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A133374 · Current
Licensed to practise in California · since 2014 · expires 2028-05-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Otolaryngology - Otolaryngology
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$215,455
Medicare paid this office $215,455 for 608 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 304 | $47,648 | $100 |
| Short return visit (20+ min) | 292 | $28,518 | $67 |
| Diagnostic exam of nasal passages using an endoscope | 102 | $22,290 | $143 |
| New patient visit (45+ min) | 143 | $18,157 | $127 |
| Exam to assess movement of vocal cord flaps using an endoscope | 71 | $15,218 | $154 |
See all 17 services
| Return visit (30+ min) | 304 | $47,648 | $100 |
| Short return visit (20+ min) | 292 | $28,518 | $67 |
| Diagnostic exam of nasal passages using an endoscope | 102 | $22,290 | $143 |
| New patient visit (45+ min) | 143 | $18,157 | $127 |
| Exam to assess movement of vocal cord flaps using an endoscope | 71 | $15,218 | $154 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $9,142 | $86 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 15 | $8,892 | $278 |
| Removal of impacted ear wax | 170 | $8,061 | $34 |
| Long return visit (40+ min) | 40 | $6,637 | $141 |
| Exam of ear using a microscope | 172 | $5,848 | $22 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 53 | $2,224 | $40 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 17 | $1,972 | $104 |
| Short return visit | 28 | $1,386 | $42 |
| Comprehensive hearing and speech recognition test | 59 | $1,351 | $23 |
| New patient visit (30+ min) | 13 | $981 | $75 |
| Test to assess middle ear function | 40 | $464 | $12 |
| Test for eardrum and muscle function | 21 | $266 | $13 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 215 | 174 | 241 | 264 | 243 | 239 |
| Diagnostic exam of nasal passages using an endoscope | 252 | 142 | 133 | 152 | 151 | 156 |
| Diagnostic exam of voice box using a flexible endoscope | 197 | 176 | 140 | 159 | 143 | 106 |
| Exam to assess movement of vocal cord flaps using an endoscope | 99 | 111 | 94 | 80 | 79 | 99 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 37 | – | 21 | – | 28 | 32 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | – | – | – | 20 | – | 19 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
608 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 15% · Women 61% · Also on Medicaid 16% · Health risk score 1.22. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 63% · Coronary heart disease 24% · Depression 24% · Atrial fibrillation 21% · Diabetes 18% · Chronic kidney disease 18% · Cancer 17% · COPD 17% · Heart failure 14% · Stroke 7% · Dementia 4%.
The office billed $1,523,893, Medicare allowed $293,039 and paid $215,455; for 2,780 services of 94 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 608 | 2,780 | 76 | 1.22 | $1,523,893 | $215,455 |
| 2023 | 686 | 3,491 | 76 | 1.13 | $1,548,342 | $219,280 |
| 2022 | 725 | 3,411 | 76 | 1.20 | $1,616,765 | $247,033 |
| 2021 | 669 | 3,112 | 76 | 1.13 | $1,227,602 | $214,874 |
| 2020 | 661 | 3,459 | 75 | 1.19 | $580,372 | $209,329 |
| 2019 | 779 | 4,436 | 75 | 1.24 | $757,648 | $254,229 |
| 2018 | 236 | 814 | 76 | 1.29 | $161,969 | $55,736 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Return visit (30+ min) | 253 | $37,419 | $98 |
| Short return visit (20+ min) | 323 | $31,457 | $70 |
| Diagnostic exam of nasal passages using an endoscope | 103 | $22,788 | $151 |
| New patient visit (45+ min) | 151 | $19,372 | $128 |
| Diagnostic exam of voice box using a flexible endoscope | 113 | $13,399 | $94 |
| Exam to assess movement of vocal cord flaps using an endoscope | 56 | $12,550 | $159 |
| Removal of impacted ear wax | 180 | $7,919 | $33 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 18 | $6,587 | $235 |
| Comprehensive hearing and speech recognition test | 193 | $6,213 | $28 |
| Exam of ear using a microscope | 200 | $5,958 | $23 |
| New patient visit (30+ min) | 63 | $5,237 | $83 |
| Long return visit (40+ min) | 34 | $5,208 | $141 |
| New patient visit (60+ min) | 12 | $2,158 | $180 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 42 | $1,828 | $40 |
| Test to assess middle ear function | 114 | $1,670 | $13 |
| Test for eardrum and muscle function | 85 | $1,486 | $17 |
| Short return visit | 21 | $1,018 | $39 |
2022: 19 services
| Return visit (30+ min) | 254 | $42,910 | $116 |
| Short return visit (20+ min) | 372 | $41,284 | $78 |
| New patient visit (45+ min) | 169 | $25,801 | $153 |
| Diagnostic exam of nasal passages using an endoscope | 108 | $22,974 | $151 |
| Diagnostic exam of voice box using a flexible endoscope | 130 | $15,446 | $97 |
| Exam to assess movement of vocal cord flaps using an endoscope | 60 | $12,382 | $155 |
| New patient visit (30+ min) | 100 | $8,317 | $83 |
| Removal of impacted ear wax | 185 | $8,014 | $30 |
| Exam of ear using a microscope | 217 | $7,627 | $23 |
| Long return visit (40+ min) | 34 | $7,231 | $164 |
| Comprehensive hearing and speech recognition test | 199 | $6,533 | $29 |
| Short return visit | 69 | $4,285 | $49 |
| New patient visit (60+ min) | 17 | $3,359 | $198 |
| Test for eardrum and muscle function | 112 | $2,146 | $17 |
| Incision, aspiration, and/or inflation of eardrum | 11 | $1,907 | $147 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 17 | $1,692 | $85 |
| Test to assess middle ear function | 101 | $1,430 | $13 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 21 | $845 | $40 |
| Test for allergy using allergenic extract injected into skin with delayed reaction analysis | 15 | $474 | $11 |
2021: 16 services
| Short return visit (20+ min) | 389 | $41,716 | $69 |
| Diagnostic exam of nasal passages using an endoscope | 101 | $22,059 | $166 |
| Return visit (30+ min) | 141 | $19,873 | $102 |
| New patient visit (30+ min) | 186 | $16,342 | $88 |
| Exam to assess movement of vocal cord flaps using an endoscope | 64 | $15,343 | $163 |
| Diagnostic exam of voice box using a flexible endoscope | 108 | $13,921 | $99 |
| New patient visit (45+ min) | 97 | $12,327 | $127 |
| Removal of impacted ear wax | 177 | $8,305 | $34 |
| Exam of ear using a microscope | 193 | $7,046 | $24 |
| Comprehensive hearing and speech recognition test | 166 | $5,628 | $30 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 13 | $5,344 | $254 |
| Long return visit (40+ min) | 20 | $3,304 | $150 |
| Short return visit | 44 | $2,068 | $42 |
| Test to assess middle ear function | 94 | $1,416 | $13 |
| Test for eardrum and muscle function | 77 | $1,393 | $17 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 11 | $245 | $16 |
2020: 17 services
| Short return visit (20+ min) | 393 | $46,032 | $60 |
| Diagnostic exam of nasal passages using an endoscope | 98 | $23,824 | $168 |
| New patient visit (30+ min) | 222 | $18,269 | $82 |
| Exam to assess movement of vocal cord flaps using an endoscope | 73 | $18,113 | $163 |
| Diagnostic exam of voice box using a flexible endoscope | 133 | $17,708 | $101 |
| New patient visit (45+ min) | 97 | $13,220 | $136 |
| Return visit (30+ min) | 99 | $10,022 | $89 |
| Exam of ear using a microscope | 222 | $9,108 | $25 |
| Removal of impacted ear wax | 134 | $6,080 | $35 |
| Comprehensive hearing and speech recognition test | 172 | $5,509 | $30 |
| Short return visit | 61 | $2,334 | $36 |
| Exam of the nose and throat using an endoscope | 14 | $1,532 | $102 |
| Test to assess middle ear function | 107 | $1,427 | $13 |
| Ct scan of face without contrast | 13 | $1,249 | $89 |
| Test for eardrum and muscle function | 69 | $1,237 | $17 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 30 | $1,211 | $40 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 11 | $231 | $16 |
2019: 21 services
| Short return visit (20+ min) | 407 | $48,855 | $59 |
| Diagnostic exam of nasal passages using an endoscope | 152 | $41,999 | $167 |
| New patient visit (30+ min) | 351 | $26,475 | $75 |
| Diagnostic exam of voice box using a flexible endoscope | 136 | $15,920 | $81 |
| Exam to assess movement of vocal cord flaps using an endoscope | 65 | $14,032 | $142 |
| New patient visit (45+ min) | 97 | $12,474 | $129 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 16 | $9,901 | $268 |
| Exam of ear using a microscope | 253 | $9,570 | $25 |
| Comprehensive hearing and speech recognition test | 249 | $8,278 | $30 |
| Removal of impacted ear wax | 166 | $7,484 | $35 |
| Return visit (30+ min) | 55 | $5,423 | $87 |
| Short return visit | 121 | $5,300 | $36 |
| Test for allergy using allergenic extract | 14 | $2,037 | $4 |
| Test for eardrum and muscle function | 121 | $1,999 | $16 |
| Test to assess middle ear function | 140 | $1,947 | $12 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 48 | $1,924 | $39 |
| Ct scan of face without contrast | 17 | $1,494 | $83 |
| Evaluation and testing for balance with recording | 11 | $957 | $87 |
| Repositioning exercises of head for treatment of dizziness, each day | 16 | $666 | $37 |
| Test to assess balance during warm and cool irrigation in both ears | 11 | $382 | $35 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 17 | $263 | $15 |
2018: 13 services
| New patient visit (30+ min) | 123 | $10,746 | $87 |
| Diagnostic exam of nasal passages using an endoscope | 52 | $10,054 | $180 |
| Short return visit (20+ min) | 95 | $7,839 | $61 |
| Exam to assess movement of vocal cord flaps using an endoscope | 18 | $2,526 | $133 |
| Removal of impacted ear wax | 60 | $2,359 | $38 |
| Comprehensive hearing and speech recognition test | 68 | $2,212 | $31 |
| Diagnostic exam of voice box using a flexible endoscope | 22 | $2,160 | $86 |
| Exam of ear using a microscope | 43 | $1,576 | $25 |
| Short return visit | 27 | $1,038 | $37 |
| New patient visit (15+ min) | 14 | $881 | $63 |
| Test for eardrum and muscle function | 38 | $682 | $17 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $544 | $42 |
| Test to assess middle ear function | 37 | $464 | $12 |
Medicaid work
$31,619 in 2024
Medicaid paid $31,619 for 530 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 224 | $13,265 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 56 | $9,119 |
| Short return visit (20+ min) | 169 | $6,374 |
| Binocular microscopy | 69 | $1,954 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $907 |
| 2024 | 530 | 5 | 27 | $31,619 |
| 2023 | 574 | 5 | 30 | $24,439 |
| 2022 | 689 | 6 | 25 | $43,493 |
| 2021 | 255 | 3 | 31 | $10,964 |
| 2020 | 455 | 4 | 38 | $14,050 |
| 2019 | 287 | 3 | 29 | $12,819 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 186 | $9,792 |
| Short return visit (20+ min) | 242 | $9,487 |
| Binocular microscopy | 115 | $3,202 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 18 | $1,341 |
| Removal of impacted ear wax | 13 | $617 |
2022
| New patient visit (45+ min) | 156 | $18,151 |
| Return visit (30+ min) | 199 | $10,960 |
| Short return visit (20+ min) | 212 | $7,751 |
| Diagnostic flexible fiberoptic laryngoscopy | 38 | $3,807 |
| Binocular microscopy | 72 | $1,915 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $909 |
2021
| Short return visit (20+ min) | 182 | $5,729 |
| New patient visit (30+ min) | 48 | $4,629 |
| Binocular microscopy | 25 | $606 |
2020
| Short return visit (20+ min) | 307 | $9,443 |
| Binocular microscopy | 124 | $2,792 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $1,286 |
| Comprehensive audiometry threshold evaluation and speech recognition | 12 | $528 |
2019
| Short return visit (20+ min) | 200 | $7,256 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 41 | $4,755 |
| Binocular microscopy | 46 | $808 |
Drugs they prescribed that Part D paid
$16,261
Pharmacies billed $16,261 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (13 of 467) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
454 generic and 13 brand-name prescriptions · $16,261 in drug cost · 51 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 89 | $3,550 | $40 |
| Azelastine | 48 | $1,662 | $35 |
| Ciprofloxacin-Dexamethasone | 15 | $1,544 | $103 |
| Fluticasone Propionate | 47 | $774 | $16 |
| Ofloxacin | 20 | $542 | $27 |
See all 11 drugs
| Ipratropium | 89 | $3,550 | $40 |
| Azelastine | 48 | $1,662 | $35 |
| Ciprofloxacin-Dexamethasone | 15 | $1,544 | $103 |
| Fluticasone Propionate | 47 | $774 | $16 |
| Ofloxacin | 20 | $542 | $27 |
| Glycopyrrolate | 13 | $450 | $35 |
| Mometasone Furoate | 26 | $273 | $11 |
| Amoxicillin-Clavulanate Potass | 21 | $233 | $11 |
| Doxycycline Hyclate | 17 | $171 | $10 |
| Mupirocin | 16 | $69 | $4 |
| Prednisone | 15 | $51 | $3 |
Year by year
| 2024 | 467 | 179 | 3% (13) | 3% | $16,261 |
| 2023 | 429 | 189 | 3% (14) | 3% | $19,896 |
| 2022 | 598 | 239 | 2% (14) | 6% | $23,682 |
| 2021 | 530 | 210 | 3% (16) | 6% | $20,646 |
| 2020 | 420 | 184 | None | 6% | $16,286 |
| 2019 | 415 | 194 | 3% (14) | 6% | $13,144 |
| 2018 | 68 | 48 | 22% (15) | None | $2,324 |
| 2017 | 59 | 43 | 56% (33) | None | $1,463 |
| 2016 | 19 | 13 | None | 0% | $350 |
| 2015 | 23 | 20 | 70% (16) | None | $383 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Ciprofloxacin-Dexamethasone | 13 | $2,335 | $180 |
| Azelastine | 55 | $2,186 | $40 |
| Ipratropium | 50 | $1,803 | $36 |
| Fluticasone Propionate | 53 | $1,027 | $19 |
| Omeprazole | 26 | $374 | $14 |
| Ofloxacin | 13 | $358 | $28 |
| Mupirocin | 20 | $244 | $12 |
| Pantoprazole | 17 | $204 | $12 |
| Amoxicillin-Clavulanate Potass | 17 | $202 | $12 |
| Famotidine | 19 | $158 | $8 |
| Montelukast | 12 | $128 | $11 |
| Prednisone | 16 | $105 | $7 |
| Mometasone Furoate | 11 | $103 | $9 |
| Hydrocodone-Acetaminophen | 11 | $54 | $5 |
2022: 15 drugs
| Azelastine | 78 | $4,734 | $61 |
| Ciprofloxacin-Dexamethasone | 26 | $4,235 | $163 |
| Ipratropium | 43 | $2,053 | $48 |
| Fluticasone Propionate | 96 | $1,547 | $16 |
| Hydrocortisone-Acetic Acid | 12 | $1,146 | $95 |
| Triamcinolone Acetonide | 18 | $733 | $41 |
| Mometasone Furoate | 31 | $675 | $22 |
| Ofloxacin | 25 | $599 | $24 |
| Pantoprazole | 45 | $549 | $12 |
| Montelukast | 28 | $532 | $19 |
| Sulfacetamide-Prednisolone | 25 | $369 | $15 |
| Amoxicillin-Clavulanate Potass | 19 | $322 | $17 |
| Prednisone | 16 | $128 | $8 |
| Omeprazole | 24 | $101 | $4 |
| Hydrocodone-Acetaminophen | 14 | $89 | $6 |
2021: 13 drugs
| Ciprofloxacin-Dexamethasone | 18 | $3,077 | $171 |
| Azelastine | 49 | $2,301 | $47 |
| Fluticasone Propionate | 115 | $1,669 | $15 |
| Hydrocortisone-Acetic Acid | 14 | $1,258 | $90 |
| Ipratropium | 19 | $1,077 | $57 |
| Pantoprazole | 73 | $814 | $11 |
| Mometasone Furoate | 20 | $717 | $36 |
| Fluocinolone Acetonide Oil | 11 | $715 | $65 |
| Ofloxacin | 22 | $448 | $20 |
| Montelukast | 30 | $336 | $11 |
| Sulfacetamide-Prednisolone | 12 | $186 | $15 |
| Prednisone | 14 | $128 | $9 |
| Hydrocodone-Acetaminophen | 12 | $116 | $10 |
2020: 10 drugs
| Azelastine | 42 | $2,044 | $49 |
| Fluticasone Propionate | 104 | $1,947 | $19 |
| Triamcinolone Acetonide | 11 | $966 | $88 |
| Ipratropium | 18 | $765 | $42 |
| Ofloxacin | 28 | $444 | $16 |
| Omeprazole | 25 | $320 | $13 |
| Pantoprazole | 26 | $241 | $9 |
| Montelukast | 13 | $126 | $10 |
| Prednisone | 20 | $115 | $6 |
| Mupirocin | 11 | $80 | $7 |
2019: 10 drugs
| Ciprodex | 14 | $3,955 | $283 |
| Fluticasone Propionate | 112 | $1,597 | $14 |
| Azelastine | 26 | $1,098 | $42 |
| Ofloxacin | 19 | $881 | $46 |
| Ipratropium | 17 | $681 | $40 |
| Omeprazole | 30 | $300 | $10 |
| Amoxicillin-Clavulanate Potass | 14 | $214 | $15 |
| Prednisone | 21 | $148 | $7 |
| Glycopyrrolate | 11 | $121 | $11 |
| Hydrocodone-Acetaminophen | 12 | $82 | $7 |
2017: 2 drugs
| Oxycodone | 13 | $299 | $23 |
| Hydrocodone-Acetaminophen | 12 | $92 | $8 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 12 | $85 | $7 |
Money from drug and device companies
$604 in 2025
| 2025 | 7 | 18 | None | $604 |
| 2024 | 5 | 11 | None | $341 |
| 2023 | 7 | 15 | None | $381 |
| 2022 | 9 | 21 | None | $563 |
| 2021 | 9 | 15 | None | $381 |
| 2020 | 4 | 6 | None | $287 |
| 2019 | 5 | 9 | None | $251 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $166 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $116 | 4 payments
|
| Inspire Medical Systems | Inspire | $112 | 1 payment
|
| Genzyme | Dupixent | $109 | 3 payments
|
| Smith+Nephew | Tula | $51 | 2 payments
|
| Aerin Medical | Vivaer Stylus | $27 | 1 payment
|
See all 18 published payments
| Genzyme | Meals · 2025-12-11 | Dupixent | $36 |
| GlaxoSmithKline | Meals · 2025-11-10 | Nucala | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-11-06 | Dupixent | $18 |
| GlaxoSmithKline | Meals · 2025-10-22 | Nucala | $22 |
| Genzyme | Meals · 2025-10-21 | Dupixent | $38 |
| GlaxoSmithKline | Meals · 2025-09-09 | Nucala | $32 |
| Regeneron Healthcare Solutions | Meals · 2025-08-15 | Dupixent | $33 |
| Optinose US | Meals · 2025-07-29 | Xhance | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-07-19 | Dupixent | $35 |
| GlaxoSmithKline | Meals · 2025-07-15 | Nucala | $33 |
| GlaxoSmithKline | Meals · 2025-05-20 | Nucala | $28 |
| Aerin Medical | Meals · 2025-05-20 | Vivaer Stylus | $27 |
| Smith+Nephew | Meals · 2025-05-15 | Tula | $31 |
| Genzyme | Meals · 2025-04-22 | Dupixent | $35 |
| Smith+Nephew | Meals · 2025-03-30 | Stravix | $20 |
| Inspire Medical Systems | Meals · 2025-03-14 | Inspire | $112 |
| Regeneron Healthcare Solutions | Meals · 2025-02-20 | Dupixent | $31 |
| GlaxoSmithKline | Meals · 2025-02-18 | Nucala | $29 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $341
| GlaxoSmithKline | Nucala | $142 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $92 | 3 payments
|
| Medtronic | Stealthstation S8 Platform | $41 | 1 payment
|
| Integra LifeSciences | Acclarent Aera | $39 | 1 payment
|
| Optinose US | Xhance | $27 | 1 payment
|
2023: $381
| Inspire Medical Systems | Inspire | $111 | 4 payments
|
| GlaxoSmithKline | Nucala | $67 | 3 payments
|
| ALK-Abello | Odactra | $61 | 3 payments
|
| Optinose US | Xhance | $46 | 2 payments
|
| Stryker | Audion Et Dilation System | $45 | 1 payment
|
| Genzyme | Dupixent | $32 | 1 payment
|
| Medtronic | Sonicision | $19 | 1 payment
|
2022: $563
| GlaxoSmithKline | Nucala | $136 | 5 payments
|
| ALK-Abello | Otiprio | $132 | 6 payments
|
| Genzyme | Dupixent | $56 | 2 payments
|
| Ethicon US | Ethicon | $48 | 1 payment
|
| Intersect ENT | Sinuva | $41 | 1 payment
|
| Aerin Medical | None | $40 | 1 payment
|
| OptiNose US | Xhance | $39 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $39 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $32 | 1 payment
|
2021: $381
| Optinose US | Xhance | $92 | 4 payments
|
| GlaxoSmithKline | Nucala | $64 | 2 payments
|
| ALK-Abello | Otiprio | $62 | 3 payments
|
| PolarityTE | None | $50 | 1 payment
|
| Stryker | Medline Industries, Inc. | $27 | 1 payment
|
| Ethicon US | Enseal X1 | $27 | 1 payment
|
| Genzyme | Dupixent | $23 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $22 | 1 payment
|
| Acacia Pharma | Byfavo | $15 | 1 payment
|
2020: $287
| Intersect ENT | Sinuva | $187 | 2 payments
|
| OptiNose US | Xhance | $44 | 2 payments
|
| Aerin Medical | Vivaer | $34 | 1 payment
|
| ALK-Abello | Otiprio | $23 | 1 payment
|
2019: $251
| Aerin Medical | Vivaer Rf Stylus | $80 | 2 payments
|
| Intersect ENT | Sinuva | $73 | 2 payments
|
| OptiNose US | Xhance | $55 | 3 payments
|
| Genzyme | Dupixent | $21 | 1 payment
|
| ALK-Abello | Odactra | $21 | 1 payment
|
Professional record
- NPI
- 1982947404
- Licence
- CA A133374California A133374: Current · expires 2028-05-31
- Trained
- University of California, San Francisco School of Medicine, 2013 · 13 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 3536 Mendocino Ave Ste 200, Santa Rosa, CA, 95403
- NPI first listed
- 2013-04-03
- NPI last updated
- 2018-08-27
This is when the NPI record was last certified, not a medical board exam.